The Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS)
The Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS)
Recruiting · NCT05926102 · Registry updated 2026-01-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS) | Disease Attributes, Genetic Risk Score, Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, disease susceptibility, inherited disease susceptibility, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Not applicable | 2026-01-13 | NCT05926102 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| VA Office of Research and Development | 472 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA | Boston | United States | 34 |